NeuroNotis (TM), a new offering for hospital customers designed to bring greater confidence to Zeto ONE's AI-enabled seizure detection. The NeuroNotis Report confirms AI-generated seizure burden ...
MIDDLETON, Wis., March 5, 2026 /PRNewswire/ -- Natus Medical Incorporated has announced the global launch of the autoSCORE™ analysis tool, spreading the availability of the first ...
RALEIGH, N.C., March 27, 2026 /PRNewswire/ -- Zeto, Inc., a medical technology company working to make brain health insights through EEG a foundational vital sign in healthcare, announced the ...
—Five abstracts presented at the 2024 Neurocritical Care Society Annual Meeting demonstrated the clinical impact of the FDA-cleared Ceribell System and Ceribell's AI-powered Clarity™ algorithm— ...
NEW YORK--(BUSINESS WIRE)--Koneksa, the evidence-based digital biomarkers company, announced today a partnership with Beacon Biosignals, the leading computational neurodiagnostics company, to launch a ...
Please provide your email address to receive an email when new articles are posted on . The trial will include a headband device and neurobiomarker platform to conduct EEG and sleep analyses in those ...
Sleep is one of the most powerful yet underutilized biomarkers in depression drug development, with objective sleep ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results